Health Wire Kuwait: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Wire Kuwait.

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Press releases published on January 14, 2026

Jan. 14, 2026

Plus Therapeutics Announces Pricing of Upsized $15 Million Public Offering

GlobeNewswire

Jan. 14, 2026

Statement from Unity Consortium on Announced Changes to the U.S. Childhood and Adolescent Immunization Schedule

GlobeNewswire

Jan. 14, 2026

Altanine Shares Industry Perspective on the Future of Generics and the Role of Value-Added Formulations

GlobeNewswire

Jan. 14, 2026

New Randomized Trial Shows Promising Cognitive Gains in Long COVID Brain Fog Using Home-Based Light Therapy

GlobeNewswire

Jan. 14, 2026

Patterson Dental and Dentsply Sirona Renew U.S. Dental Technology Distribution Partnership

GlobeNewswire

Jan. 14, 2026

Emergent BioSolutions Receives U.S. FDA Approval on Supplemental New Drug Application for NARCAN® Nasal Spray to be Packaged in a New Carrying Case, Making Life-Saving Naloxone More Accessible for Everyday Preparedness

GlobeNewswire

Jan. 14, 2026

Glucose Health, Inc. Reports Debt-Free Balance Sheet and Previews New Soluble Fiber Brand

GlobeNewswire

Jan. 14, 2026

NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA in Support of NRX-100 Approval

GlobeNewswire

Jan. 14, 2026

C4 Therapeutics Outlines Strategic Milestones to Advance Cemsidomide as a Potential Best-in-Class IKZF1/3 Degrader and Discovery Strategy Focused on Novel Targets in Clinically Validated Pathways

GlobeNewswire

Jan. 14, 2026

RetinalGenix Reports on its Science and Mission in Light of New AI-Driven Retinal Mapping Study

GlobeNewswire

Jan. 14, 2026

Verano Strengthens National Product Portfolio in Industry’s Fastest-Growing Category with Launch of Swift Lifts as Standalone Pre-roll Brand

GlobeNewswire

Jan. 14, 2026

Human Appeal Concludes First-Ever U.S. Winter Coat Drive

GlobeNewswire

Jan. 14, 2026

[Latest] Global T-Cell Engagers Market Size/Share Worth USD 18.8 Billion by 2034 at a 21.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

GlobeNewswire

Jan. 14, 2026

Sisäpiiritieto: Orion antaa näkymäarvion vuodelle 2026 ja arvioi Orionin kirjaamalla vuotuisella Nubeqa®-liikevaihdolla olevan potentiaalia ylittää tulevaisuudessa miljardi euroa

GlobeNewswire

Jan. 14, 2026

Inside information: Orion provides outlook for 2026 and estimates that the annual Nubeqa® net sales recorded by Orion has potential to exceed EUR 1 billion in the future

GlobeNewswire

Jan. 14, 2026

De nouvelles données renforcent l’engagement d’Ipsen à proposer des solutions et à combler les lacunes de prise en charge dans les maladies neurologiques lors du congrès TOXINS

GlobeNewswire

Jan. 14, 2026

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

GlobeNewswire

Jan. 14, 2026

HUTCHMED Highlights Publication of Phase III SACHI Results in The Lancet

GlobeNewswire

Jan. 14, 2026

BriaCell Therapeutics Announces Pricing of $30 million Public Offering

GlobeNewswire